<SEC-DOCUMENT>0001628280-26-049937.txt : 20260728
<SEC-HEADER>0001628280-26-049937.hdr.sgml : 20260728
<ACCEPTANCE-DATETIME>20260728083519
ACCESSION NUMBER:		0001628280-26-049937
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20260723
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260728
DATE AS OF CHANGE:		20260728

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bicara Therapeutics Inc.
		CENTRAL INDEX KEY:			0002023658
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42271
		FILM NUMBER:		261207628

	BUSINESS ADDRESS:	
		STREET 1:		116 HUNTINGTON AVENUE SUITE 703
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		617-468-4219

	MAIL ADDRESS:	
		STREET 1:		116 HUNTINGTON AVENUE SUITE 703
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bcax-20260723.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019fa50d-f3b6-7741-b8ab-5621f157b669,g:c6e2c908-23a2-42fe-a9a4-6c3cc9b7cb97,d:6d955e2eb11f40b0a8a37a892556a7ef-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bcax-20260723</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-23">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-24">0002023658</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bcax-20260723.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0002023658</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-23</xbrli:startDate><xbrli:endDate>2026-07-23</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i6d955e2eb11f40b0a8a37a892556a7ef_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">___________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">___________________________________</span></div><div style="margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">July 23, 2026</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">___________________________________</span></div><div style="margin-top:2.7pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Bicara Therapeutics Inc.</ix:nonNumeric></span></div><div style="margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">___________________________________</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.92pt;padding-right:0.92pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></div><div style="padding-left:0.92pt;padding-right:0.92pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(State or other jurisdiction of </span></div><div style="padding-left:0.92pt;padding-right:0.92pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">incorporation or organization)</span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.95pt;padding-right:0.95pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-42271</ix:nonNumeric></span></div><div style="padding-left:0.95pt;padding-right:0.95pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Commission File Number)</span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.95pt;padding-right:0.95pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">83-2903745</ix:nonNumeric></span></div><div style="margin-bottom:0.08pt;padding-left:0.95pt;padding-right:0.95pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%">(I.R.S. Employer Identification Number)</span></div></td></tr><tr><td colspan="9" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.92pt;padding-right:3.92pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">116 Huntington Avenue,</ix:nonNumeric></span></div><div style="margin-bottom:0.08pt;padding-left:3.92pt;padding-right:3.92pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">Suite 703</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Boston</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-10">MA</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">02116</ix:nonNumeric></span></div></td></tr><tr><td colspan="9" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.37pt;padding-right:4.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices and zip code)</span></div></td></tr><tr><td colspan="9" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">617</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">468-4219</ix:nonNumeric></span></div></td></tr><tr><td colspan="9" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.37pt;padding-right:4.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Registrant's telephone number, including area code)</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:2.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">___________________________________</span></div><div style="margin-top:10.8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.852%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:92.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.4pt;padding-right:1.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.9pt;padding-right:1.9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.4pt;padding-right:1.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.9pt;padding-right:1.9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.4pt;padding-right:1.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.9pt;padding-right:1.9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.4pt;padding-right:1.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.9pt;padding-right:1.9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.823%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.4pt;padding-right:4.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:1.4pt;padding-right:1.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Title of each class</span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:1.4pt;padding-right:1.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Trading Symbol</span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:1.4pt;padding-right:1.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Common Stock, $0.0001 par value</ix:nonNumeric></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">BCAX</ix:nonNumeric></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:middle"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">The Nasdaq Global Market</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:5.4pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5.4pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="f-21">&#9746;</ix:nonNumeric></span></div><div style="margin-top:5.4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#181717;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="f-22">o</ix:nonNumeric></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 5.02. Departure of Directors or Certain Officers&#894; Election of Directors&#894; Appointment of Certain Officers&#894; </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Compensatory Arrangements of Certain Officers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Resignation of Kiran Mazumdar-Shaw</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On July 23, 2026, Kiran Mazumdar-Shaw resigned from the Board of Directors (the &#8220;Board&#8221;) of Bicara Therapeutics Inc. (the &#8220;Company&#8221;) and her position on the Nominating and Corporate Governance Committee of the Board (the &#8220;Nominating and Corporate Governance Committee&#8221;), effective as of July 28, 2026. Ms. Mazumdar-Shaw&#8217;s decision to resign from the Board was not the result of any disagreement with the Company on any matter relating to the operations, policies or practices of the Company. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Appointment of Jeremy Bender, Ph.D. and Christy Oliger</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On July 26, 2026, upon the recommendation of the Nominating and Corporate Governance Committee, the Board appointed (i) Jeremy Bender, Ph.D. to serve on the Board as a Class I director to hold office until the Company&#8217;s annual meeting of stockholders in 2028 or until his earlier death, resignation or removal, and (ii) Christy Oliger to serve on the Board as a Class II director to hold office until the Company&#8217;s annual meeting of stockholders in 2029 or until her earlier death, resignation or removal, with each appointment to be effective as of July 28, 2026 (the &#8220;Appointment Date&#8221;). The Board determined that each of Dr. Bender and Ms. Oliger is independent under the applicable listing standards of the Nasdaq Global Market. In connection with these appointments, the Board increased the authorized size of the Board from nine to ten directors, effective as of the Appointment Date.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As non-employee directors, Dr. Bender and Ms. Oliger will receive compensation, including an initial non-qualified stock option award of 38,950 shares of the Company&#8217;s common stock and cash compensation for their Board and committee service, in accordance with the Company&#8217;s Second Amended and Restated Non-Employee Director Compensation Policy, a copy of which the Company intends to file with the SEC as an exhibit to the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ending September 30, 2026. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Dr. Bender and Ms. Oliger are not parties to any transaction with the Company that would require disclosure under Item 404(a) of Regulation S-K, and there are no arrangements or understandings between Dr. Bender and Ms. Oliger and any other persons pursuant to which they were selected as directors. In addition, Dr. Bender and Ms. Oliger have each entered into an indemnification agreement with the Company consistent with the form of indemnification agreement, a copy of which was previously filed as Exhibit 10.4 to the Company&#8217;s Registration Statement on Form S-1/A on September 6, 2024.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Board Committee Updates</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Effective as of the Appointment Date, the Board appointed (i) Dr. Bender to serve as a member of the Audit Committee of the Board (the &#8220;Audit Committee&#8221;), replacing Carolyn Ng, Ph.D., (ii) Ms. Oliger and Dr. Ng to serve as a members of the Nominating and Corporate Governance Committee, replacing Ms. Mazumdar-Shaw and Jake Simson, Ph.D., and (iii) Dr. Bender, Ms. Oliger and Kate Haviland to serve as members of the newly formed Launch Readiness Committee of the Board (the &#8220;Launch Readiness Committee&#8221;), with Ms. Haviland as chair of the Launch Readiness Committee, each until their respective successors are elected and qualified, or until their earlier death, resignation or removal, or until otherwise determined by the Board. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Launch Readiness Committee was formed as of the Appointment Date for the purpose of providing strategic and operational guidance to management of the Company in connection with the Company&#8217;s commercialization strategy and launch readiness and to advise the Board with respect to strategic commercial considerations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Board has determined that Dr. Bender meets the requirements for independence of audit committee members under the applicable listing standards of the Nasdaq Global Market and the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As a result of the changes described above, the members of the committees of the Board are as follows:</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.428%"><tr><td style="width:1.0%"/><td style="width:45.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:52.604%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Audit Committee</span></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">Scott Robertson (Chair)</span></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.15pt">Michael Powell, Ph.D.</span></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.15pt">Jeremy Bender, Ph.D.</span></div><div style="margin-bottom:0.08pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:0.08pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Compensation Committee &#8211; no changes</span></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">Michael Powell, Ph.D. (Chair)</span></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.15pt">Christopher Bowden, M.D.</span></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.15pt">Kate Haviland</span></div><div style="margin-bottom:0.08pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Nominating and Corporate Governance Committee</span></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.15pt">Michael Powell, Ph.D. (Chair)</span></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.15pt">Carolyn Ng, Ph.D.</span></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.15pt">Christy Oliger</span></div><div style="margin-bottom:0.08pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:0.08pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Launch Readiness Committee</span></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">Kate Haviland (Chair)</span></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.15pt">Jeremy Bender, Ph.D.</span></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.15pt">Christy Oliger</span></div><div style="margin-bottom:0.08pt;text-align:justify"><span><br/></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Dr. Powell continues to serve as Chair of the Board.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 7.01. Regulation FD Disclosure. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On July 28, 2026, the Company issued a press release titled &#8220;Bicara Therapeutics Announces Appointments of Jeremy Bender and Christy Oliger to Board of Directors.&#8221; A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The information set forth under Item 7.01, including Exhibit 99.1, is intended to be furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 - Financial Statements and Exhibits</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(d) The following exhibits are being filed herewith:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.734%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.252%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt 1.5pt 2.5pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline">Exhibit No.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt 1.5pt 74.5pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline">Description</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:0.9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="july2026boardupdatespr_fin.htm">99.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;padding-left:0.9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="july2026boardupdatespr_fin.htm">Press Release, dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="july2026boardupdatespr_fin.htm">July 28</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="july2026boardupdatespr_fin.htm">, 2026</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="july2026boardupdatespr_fin.htm">, furnished </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="july2026boardupdatespr_fin.htm">herewith</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="july2026boardupdatespr_fin.htm">.</a></span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.9pt;padding-right:1.85pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.9pt;padding-right:1.9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"><tr><td style="width:1.0%"/><td style="width:39.477%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.626%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.042%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:1.5pt 1pt 1.5pt 2pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:125%">Bicara Therapeutics Inc.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Date: July 28, 2026</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="padding-left:1pt;padding-right:1.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></div></td><td colspan="3" style="padding:1.5pt 1pt 1.5pt 2pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">/s/ Claire Mazumdar</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="padding-left:1pt;padding-right:1.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Name:</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 2pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Claire Mazumdar, Ph.D.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="padding-left:1pt;padding-right:1.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Title:</span></div></td><td colspan="3" style="padding:1.5pt 1pt 1.5pt 2pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Chief Executive Officer</span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>july2026boardupdatespr_fin.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="ic67622bc5910420380d81b7776b45f34_1"></div><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><img alt="image_0.jpg" src="image_0.jpg" style="height:78px;margin-bottom:5pt;vertical-align:text-bottom;width:297px"></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:125%">Bicara Therapeutics Announces Appointments of Jeremy Bender and Christy Oliger to Board of Directors </font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">BOSTON, July 28, 2026 &#8211;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> Bicara Therapeutics Inc. (Nasdaq&#58; BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced the appointments of Jeremy Bender, Ph.D., MBA and Christy Oliger to its Board of Directors. Dr. Bender, who most recently served as Chief Executive Officer at Day One Biopharmaceuticals through its acquisition by Servier in 2026, brings more than 20 years of corporate strategy and operating experience in biotechnology to Bicara. Ms. Oliger brings more than 30 years of commercial and operating experience in global biopharmaceutical organizations, having most recently served as Senior Vice President of the Oncology Business Unit at Genentech. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#34;We are delighted to welcome Jeremy and Christy to our Board of Directors at this pivotal time for Bicara. Together, they bring deep commercial, strategic, and operational expertise that will be invaluable as we continue our evolution from a clinical-stage organization to one focused on successfully delivering ficerafusp alfa to patients,&#8221; said Claire Mazumdar, Ph.D., MBA, Chief Executive Officer of Bicara Therapeutics. &#8220;Each of these distinguished professionals has an established track record of guiding innovative biopharmaceutical companies through critical stages of growth, including pipeline development, corporate strategy, and commercialization. Their perspectives will strengthen our Board as we advance our portfolio, execute on our long-term vision, and continue building Bicara into a mature biopharmaceutical organization.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In addition, Kiran Mazumdar-Shaw has retired from Bicara&#8217;s Board of Directors. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#34;As one of our founding Board members, Kiran has been instrumental in shaping Bicara from its earliest days. Her impact extends beyond the initial seed capital that helped launch the company, but also the strategic guidance and steadfast support that has enabled Bicara to advance ficerafusp alfa into the clinic and reach the important milestone of a registration-enabling clinical study,&#8221; said Mike Powell, PhD, Chairman of Board of Bicara Therapeutics.  &#8220;On behalf of the Board, management team, and Bicara employees, I want to thank Kiran for her vision, leadership, and indelible contributions to Bicara.&#8221; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">About Jeremy Bender, Ph.D., MBA</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Dr. Bender most recently served as Chief Executive Officer, President and a member of the Board of Directors of Day One Biopharmaceuticals, Inc. from September 2020 to April 2026, where he led the company through its evolution into a commercial-stage oncology company, including the approval and launch of OJEMDA&#174; for pediatric low-grade glioma and the company's approximately $2.5 billion acquisition by Servier in 2026.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Prior to joining Day One, Dr. Bender was Vice President of Corporate Development at Gilead Sciences, Inc., a pharmaceutical company, from March 2018 to September 2020. Prior to that, he was Chief Operating Officer of Tizona Therapeutics, Inc. from July 2015 to March 2018 and Chief Business Officer </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">of Sutro Biopharma, a biotechnology company specializing in cancer and autoimmune therapeutics, from October 2012 to July 2015. Prior to joining Sutro Biopharma, Inc., he was Vice President of Corporate Development at Allos Therapeutics Inc., a biotechnology company focused on cancer treatments, from January 2006 to September 2012. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Dr. Bender began his career in the life sciences practice at Boston Consulting Group, a management consulting company. Dr. Bender also sits on the boards of Mereo BioPharma Group plc and Aura Biosciences, Inc. From October 2023 to June 2024, Dr. Bender also served as a director of Fusion Pharmaceuticals, Inc., a biopharmaceutical company. Dr. Bender holds a B.S. in Biological Sciences from Stanford University, a Ph.D. in Microbiology and Immunology from the University of Colorado, and an MBA from the MIT Sloan School of Management.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">About Christy Oliger</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ms. Oliger is recognized for building industry leading capabilities and teams and was the Senior Vice President, Business Unit Head for Oncology and Genentech from 2017-2020, managing a portfolio of 15 products, contributing U.S. revenue exceeding $13 billion, delivering launches in lung cancer, breast cancer, chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma (NHL), melanoma and leading an organization of more than 800 people. Prior to this role,&#160;Ms. Oliger served as Senior Vice President and Business Unit Head, Neurology, Rare Disease, Infectious disease where she was responsible for building the teams and driving successful launches in multiple sclerosis (MS) (Ocrevus&#174;), hemophilia (Hemlibra&#174;) and spinal muscular atrophy (SMA) (Evrysdi&#174;), together the most significant growth drivers in the U.S. business. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Prior to these roles, she spent three years as Global Head of Portfolio and Project Management where her team was responsible for the Late-Stage Portfolio Committee comprised of a late-stage development portfolio of greater than 300 projects across multiple therapeutic areas. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Christy began her career in life sciences at Schering Plough, a pharmaceutical company.  In addition to Bicara, Christy also currently sits on the boards of Vera Therapeutics, Karyopharm Therapeutics, and Replimune Inc.  She previously served as a director at Nuvalent Inc. prior to acquisition by GSK, Sierra Oncology prior to acquisition by GSK, Reata Pharmaceuticals prior to acquisition by Biogen, Rayze Bio prior to acquisition by BMS, and Lava Oncology prior to acquisition by Xoma Therapeutics.  She holds a B.A. in Economics from University of California, Santa Barbara.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">About Bicara Therapeutics </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bicara is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Bicara has built a platform designed to facilitate the development of bifunctional therapies that precisely target the tumor and deliver a tumor-modulating payload to the tumor site. This approach was deployed in the development of Bicara&#8217;s lead program ficerafusp alfa, formerly BCA101, a bifunctional epidermal growth factor receptor (EGFR) directed monoclonal antibody bound to a human transforming growth factor beta (TGF-&#946;) ligand trap. By combining these two clinically validated targets, ficerafusp alfa has the potential to exert potent anti-tumor activity by simultaneously blocking both cancer cell-intrinsic EGFR survival and proliferation, as well as the immunosuppressive TGF-&#946; signaling within the tumor microenvironment (TME). Ficerafusp alfa directs the TGF-&#946; inhibitor into the immediate TME through the binding of EGFR on tumor cells, which Bicara believes will lead to deep and durable responses and an increase in overall survival, while reducing the potential</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">adverse effects previously</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">associated with systemic TGF-&#946; inhibition. Ficerafusp </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">alfa is being developed in head and neck squamous cell carcinoma, where there remains a significant unmet need, as well as other solid tumor types. For more information, please visit&#160;www.bicara.com&#160;or follow us on LinkedIn and X.</font></div><div style="padding-left:2.15pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Forward-Looking Statements</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may be identified by words such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;seek,&#8221; &#8220;predict,&#8221; &#8220;future,&#8221; &#8220;project,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;target&#8221; and similar words or expressions, or the negative thereof, are intended to identify forward-looking statements, although not all contain identifying words. Any statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements include, without limitation, express or implied statements regarding Bicara&#8217;s strategy, business plans and focus&#59; the clinical development of ficerafusp alfa, including planned and ongoing clinical trials&#59; the expected therapeutic potential and clinical benefits of ficerafusp alfa, including potential efficacy, depth, durability and tolerability&#59; Bicara&#8217;s ability to scale and prepare for potential commercialization of ficerafusp alfa&#59; the potential for U.S. regulatory approval and launch of ficerafusp alfa&#59; and anticipated contributions of members of Bicara&#8217;s Board of Directors. Any forward-looking statements in this press release are based on management's current expectations and beliefs and are subject to a number of risks and uncertainties that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks relating to Bicara&#8217;s research and development activities&#59; Bicara&#8217;s ability to execute on its business plans and strategy, including obtaining the requisite regulatory approvals on the expected timeline, if at all&#59; uncertainties relating to the clinical development of ficerafusp alfa&#59; the Company&#8217;s dependence on third parties&#59; risks related to the Company&#8217;s financial condition and need for additional funds in order to commercialize ficerafusp alfa, if approved&#59; risks related to regulatory developments and approval processes of the U.S. Food and Drug Administration and comparable foreign regulatory authorities&#59; risks related to establishing and maintaining Bicara&#8217;s intellectual property protections&#59; and risks related to the competitive landscape for ficerafusp alfa&#59; as well as other risks described in &#8220;Risk Factors,&#8221; in Bicara&#8217;s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, as well as discussions of potential risks, uncertainties, and other important factors in Bicara&#8217;s subsequent filings with the U.S. Securities and Exchange Commission (SEC). In addition, any forward-looking statements represent Bicara&#8217;s views only as of today and should not be relied upon as representing its views as of any subsequent date. Bicara explicitly disclaims any obligation to update any forward-looking statements. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Bicara intends to use its Investor Relations website as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor the Company&#8217;s Investor Relations website, in addition to following the Company&#8217;s press releases, SEC filings, public conference calls, presentations, and webcasts.</font></div><div style="margin-bottom:8pt;padding-left:2.25pt"><font><br></font></div><div style="margin-bottom:8pt;padding-left:2.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Contacts</font></div><div style="margin-bottom:8pt;padding-left:2.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Investors<br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Rachel Frank <br>IR&#64;bicara.com</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:2.15pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Media</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"><br>Tim Palmer</font></div><div style="padding-left:2.15pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Tim.Palmer&#64;bicara.com </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>bcax-20260723.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019fa50d-f3b6-7741-b8ab-5621f157b669,g:c6e2c908-23a2-42fe-a9a4-6c3cc9b7cb97-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bcax="http://www.bicara.com/20260723" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bicara.com/20260723">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bcax-20260723_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bcax-20260723_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.bicara.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>bcax-20260723_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019fa50d-f3b6-7741-b8ab-5621f157b669,g:c6e2c908-23a2-42fe-a9a4-6c3cc9b7cb97-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019fa50d-f3b7-7235-875f-060638ae8a50_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019fa50d-f3b7-7f7a-b33f-8131bc80aab4_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019fa50d-f3b7-7368-bdbc-4003427856f6_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019fa50d-f3b7-71f4-bcf1-fa4827b6b458_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019fa50d-f3b7-7200-82ac-9a8c76eddb94_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_019fa50d-f3b7-7904-8673-6100c611c760_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_019fa50d-f3b7-7525-a9bb-4b284e52600f_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019fa50d-f3b7-75d5-92d5-7b4b51d81255_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019fa50d-f3b7-7d7d-8812-95804df1eb74_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_019fa50d-f3b7-76f2-ae1f-3bdcf5f6695d_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019fa50d-f3b7-7290-a6ea-2a86eb62e746_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_019fa50d-f3b7-7d0c-b5d0-bb2a3084644d_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_019fa50d-f3b7-7737-a61b-8f9dd6e75290_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019fa50d-f3b7-7777-a1d4-2b06c1de0c6d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019fa50d-f3b7-795d-9b39-792c40552587_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019fa50d-f3b7-7980-a5ed-fead9195f471_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019fa50d-f3b7-7aa6-bd48-075abfef3ed4_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019fa50d-f3b7-7ed9-9b64-30b1f8ea0a56_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019fa50d-f3b7-7aa9-84f6-6e35bb7cc717_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019fa50d-f3b7-72f7-885d-efda43f49187_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019fa50d-f3b7-76da-bc1b-cf5347bc1397_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_019fa50d-f3b7-7bfd-98eb-62205f018d7f_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019fa50d-f3b7-726a-9896-2225240be204_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019fa50d-f3b7-76ab-b4f8-83c983043924_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>bcax-20260723_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019fa50d-f3b6-7741-b8ab-5621f157b669,g:c6e2c908-23a2-42fe-a9a4-6c3cc9b7cb97-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bicara.com/role/Cover" xlink:type="simple" xlink:href="bcax-20260723.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.bicara.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019fa50d-f3b7-71c9-a307-40d5b540fda7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_DocumentType_019fa50d-f3b7-71c9-a307-40d5b540fda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019fa50d-f3b7-74bc-998f-a99ed992d8ae" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_DocumentPeriodEndDate_019fa50d-f3b7-74bc-998f-a99ed992d8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019fa50d-f3b7-7171-a7b5-c10b7f043794" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_EntityRegistrantName_019fa50d-f3b7-7171-a7b5-c10b7f043794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019fa50d-f3b7-7374-be23-8cfded685161" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019fa50d-f3b7-7374-be23-8cfded685161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019fa50d-f3b7-7ce9-8e99-e330a3301710" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_EntityFileNumber_019fa50d-f3b7-7ce9-8e99-e330a3301710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019fa50d-f3b7-763c-8840-0f22c6c892ce" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_EntityTaxIdentificationNumber_019fa50d-f3b7-763c-8840-0f22c6c892ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019fa50d-f3b7-7381-93ea-8327a262c33d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_EntityAddressAddressLine1_019fa50d-f3b7-7381-93ea-8327a262c33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_019fa50d-f3b7-76e7-bdc4-36b87d6fc4c3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_EntityAddressAddressLine2_019fa50d-f3b7-76e7-bdc4-36b87d6fc4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019fa50d-f3b7-7732-9161-14afaf587484" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_EntityAddressCityOrTown_019fa50d-f3b7-7732-9161-14afaf587484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019fa50d-f3b7-72aa-858d-0f9ceac8c276" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_EntityAddressStateOrProvince_019fa50d-f3b7-72aa-858d-0f9ceac8c276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019fa50d-f3b7-7d30-8852-0068b87858fd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_EntityAddressPostalZipCode_019fa50d-f3b7-7d30-8852-0068b87858fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019fa50d-f3b7-7d5d-b0e7-025283b827bf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_CityAreaCode_019fa50d-f3b7-7d5d-b0e7-025283b827bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019fa50d-f3b7-79be-97d5-d23b46638ecd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_LocalPhoneNumber_019fa50d-f3b7-79be-97d5-d23b46638ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_019fa50d-f3b7-7e62-bdf4-2b2a932fdf05" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_WrittenCommunications_019fa50d-f3b7-7e62-bdf4-2b2a932fdf05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_019fa50d-f3b7-7c00-b5a2-a83de77a7694" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_SolicitingMaterial_019fa50d-f3b7-7c00-b5a2-a83de77a7694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_019fa50d-f3b7-7785-8e20-9f2bd08a6a01" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_PreCommencementTenderOffer_019fa50d-f3b7-7785-8e20-9f2bd08a6a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_019fa50d-f3b7-7be0-ab63-c729808a9747" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_019fa50d-f3b7-7be0-ab63-c729808a9747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019fa50d-f3b7-7ec8-a270-53762941042c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_Security12bTitle_019fa50d-f3b7-7ec8-a270-53762941042c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019fa50d-f3b7-7a16-8653-32c77514e5c8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_TradingSymbol_019fa50d-f3b7-7a16-8653-32c77514e5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019fa50d-f3b7-7543-b2c4-737eec99bae7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_SecurityExchangeName_019fa50d-f3b7-7543-b2c4-737eec99bae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019fa50d-f3b7-74dc-b651-965731276ff2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_EntityEmergingGrowthCompany_019fa50d-f3b7-74dc-b651-965731276ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_019fa50d-f3b7-7acd-b294-30f5b9fe701d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_EntityExTransitionPeriod_019fa50d-f3b7-7acd-b294-30f5b9fe701d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019fa50d-f3b7-7ecd-a7b2-50a92d74be4b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_AmendmentFlag_019fa50d-f3b7-7ecd-a7b2-50a92d74be4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019fa50d-f3b7-715e-a8a3-2147709f2c24" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019fa50d-f3b7-7ba1-bf82-ad39a8fc0bd5" xlink:to="loc_dei_EntityCentralIndexKey_019fa50d-f3b7-715e-a8a3-2147709f2c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
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M)[2+*_FX0BI[C WW\^]<QK'4N.)V_K=%'#_FN)G/YT9MXW?Y_*[D<[A4^["
M8Q['7(ZZ<71:S=&)_'WMQC<_JAKT/JG4Z?!T4#:7]IXVBW;&W08       "
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M9BI;C.6XM-I*18.M"B?-_W%A8W4OURJ?6JWX_A;?USZ<J>K%"2F)D]-K\(D
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M7"6P>I# J9(X-D61WALNK.-8*:OC9=BQ<N$,/K;+P.MQ.>V$3Q@       #
M%J.VSLMHF#Q82X6$L70DQ]C,%R?S WG#N/!MG=JEXHIJ@&_1XN3 L\;)P%SZ
M0>8IEZU0,HNG/U:,=W@Z2-MB,E\?&=I\JW;QZ:H*)R")\Z+DV_JJ2NGNE,2Q
MS?.5#Z<J3V-J#3ITHJ6]TGM.*G+05@4       #PRO*<7B7S2=0\&B45)MJ'
MSQH;+C8N7J==_*6VX5Y^"'^"OUY75=ZT>NZ+S)I9S?&(]G2M=F0YQIDZ'=SJ
M:U4[G5[78>EPXTCQ=5K(UTA:J3:@E>HEVZJ>'W;LPL,<=_$UNYKOX9FZ44PV
M#7KWIKE&\A[$)Q$       #@)4C5S;19M+,,*#:>WJ8;=#0?3Y&*&^/BKU/"
MQ*;DR3:3&$B5.#9<+?-X,DL?E@'+:@:-D!:G5ERSM(DKI]?69M.A?)VZC(\_
M2ZU"9<L0$C>O'#U\_WXO[7#\]=<S3R=K1\=(-8[,&)J4TRZ8CP,       #P
M%Z;*9B!+AZ=J%A=.DQ70IA&[C8^_,FGNC*SS;GF[U%\+J01:PM&M/'U>JCBR
M+MJ_57-59*#QIE8S[8H:QR4<BU*R"PF:S5@_'I_D6)9:\EQQC?;A(NUIAG'T
ML:Q!1Z@ZC<(G$P       . %E*<#9"@P/UB?Q0_5UQ@?EO,#]:JJ)2CT0ZO4
M9@\V-BXNY^,W^<%_DG)TE&S,:MV5H[8I,VFD:C3?IUW?I[4KOF5<6(H$S6;>
MOW+0<5_57O6DMO%_M*5YF:<3^/WX%GPR 0      8/ F:[IIZ$DY[2@KN*5=
M2MJ/,D>=_#"]P+AX0YI/4@[D[=D&JVY>*J22XU;CPK_I!DTV]9Z#U0(:D>?T
MZI9<SYQV,+[G+:K>/%:[YBR^AC=5Y_0<!AIO46SD:_8[CAOYZPN4"Z?) &W5
MH'=T?)5VE_>LO'?Q"08      (#!D<#):0=^&-Y-G44'9(Z,<72>MO%ZX^+M
MVH85U:#9,GFS;5;>_&6LY_-\B.-.X\.797[/U'FTAR1Q6G$]9>CN^%E/I?E!
MF:?Q?#Z7E-N6PF-5=0F2,YL71;79[!'MHR01;Y;AT-K1B6HN'2B556.GTW!\
M@@$      & [1FTRX%>J;CH<[:<:?:/UG&*<]G1V.8,DRF:@9P?P@_]&D^;T
M%-VZ44Q3#1J=S:6]TT#C%FXU2G.$/)UN7'%=F<2)&Y"8V;IJ'.7"T_S>7*)]
MN%#:^V3&D;3ZI>0COY>Q;AP       "V.])ZDCEZ4X>CHW2#-#\4UXTO+M>N
MN)4?E!^L*A]Z!N3#OJW65-MT_G?R:[N28X9R] %YT)<-6ZU:39UU;=S?U(M_
MY?/P52O56B1CMG;(<5C/\3B_1Q?S\2I^GYZ16>HPL_K>JV;3OJUJD0,
M  !H&4EBR&:?S-$4X\)YQL?;C ]/:1^>JQZ6XW;PT!]3(LJ'A[2/UY[0**:J
MLVE7::5JU6IQ664^N:OGP%I7\Y_Y.E_&Y_,4DC%_P_W<E)QSH9?C#O[S1;I>
MG*BZ:+3,Q,$G&P    #@S_P1  #__^Q="9@4U;4>%F6ZJH<=$429KBIF6)1
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MN98E@[%P9D2IU*-]M'Y"OXH>Z"12KQ (.89>>J2D9T77XA.&2)%23<WV.G'
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M'R-$*]X6W0>*,![.#2J+\1"5CW*B3[G"2KL653B8(ZM0*LP0@=,T[SY1UM[
M\8R5\O@AAJ)?!.O!:)XK#O/E]![6XS-G/[<4J3F*UD6EU<6H:D2E(R=8@WW:
M[F8D_/'OUL-\V1WA^=+BTSJ6:J7M>^F=26E5H#!2+(JA/&:2#34=-LMRT_>#
MP_XZ.)R;R>'.B.VP'/\=)'$,QY]IN/O*JY%<N3>SN7"0J#-FL,B%2-:E6&<D
M#WAE)%1=V?4G&C8;9"79$%0%)6SV7:X2<3S#=+SO(;%C83)KU[\!/B^!>W\
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MO -LID5%'2'*ZBQ,U L;UE5A2?"MH>*$QO>7;_*QY/"+(6EY0XD<G]H>*]-
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M=/8R+4,F N>_JR4P?A_G1412JS#I+M@BN,=G!$I4W*3JL[ JVUH8@TM$2;T
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M-3_:;5A-.0-Q@@/@1!,("NC_!W/W758^A1H_06<%:H](<?W"6#PYI2-8@0+
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M (>*RPY2]T%Q603'X/L7HEBF2-J*@GFS@;]M?XEJ0,G:W/)$4N_??V(4@;<
M #BE)2.IF\SNJ'_# "CM"[B.]=Q1)LCCLP[6I%=Q7")QM'I7]^&LJ, [ PD
M)P!:.(JV'.;1ZY*LGA^!-8&Z&S%0-]A[,'G,H)A2?; DZV<R!S[J5!>&,4,6
MT0-4QR^A'UX63PX6.^XB;C]!5H)-#C =4F?9_B60[+W&'9ERH6(BN'XK= 2E
M7F6:(/Y9*=3Z29/])\]I&H @1VWFP[+)3O-@%'R=XN8:3==;P.]%-E )O>TO
M,1WO9OCY=!C7<<9<TE-$^N8V,4.BAM.TEY7.[F\YGF&YOH.:3YQYMHG&2KAT
M<5I-)[_><O.O4!8.7K--?B#B0@ XHG>(E2HFM3? YNZ0GON-Z3V@'<4;NRJ
MTR8N*Z&X[&:WC^80)-A!?\N^GNJL*-H+446_##;^QY<K6DTDH0Y@UM6!<)XI
MQ?-%W1X4\&1E'S0A:PV0'?"W)=&?1F7]#60612IK-+H>A<!67  X 6#E,7!W
M%?Q\8TQ6ZWHFDDI0'>J^\AQ.J/O 'NPXYKRG/<>%W$.A909CM0C6];_$%/T7
MTI#1!X@==U$V4HH"M\;99 ^CD1QEN>0\?$//G9C"DKCF.9L"P9O5M)3$]>Z
M9/T4+"]"C9@M]6'P?L#O91.0B9/V4F8Z?S?\ORNIJ'&P$OKEAIU_Q'#\WYF-
MWC&3&HFPA/N&AF-?EVF1C30Y"&)CEN7F[X+8^ CFP9=<P#M<3!S7_]1PO ?A
M>#ZRLU)S2/^N+G(M )SOW7%SULP3N#7\/-J[KZ(]3IT=5O/O61MAW\D3+-4O
M1MHR@BSE"6UB7Q@K6DHB )SOV8R=D,6!VB31N'I:)*[=QMDW:X,'[M%8S?&R
MG&8^;YMX++?U)OZW%@X@9+>@YN>+"*C,\G-%\.8Y"1(TM SN%4\.ILR;8-E5
M=T.1U9BB6;"N_I:"42%B!498/*V+QO4;L;0MEAC;KZ)B?.!9V44&X.0YV.=U
M8/>+;!W8'C#GGS"_9I8GJG4*[@:WP5XYTRTRN%J'?8E#V3=Q[6V^'H9AO<!2
MV&5117\9'1Z19;0%$"_RA&)I,ZXFNQ@9$JM+MXZP''*FY>0?A,3UK9#I@60I
M^ *)*US?8V@CC24D]>G<02F'#$2!7Y; MF%:I!23>@1QT,7)=',7F6[^69/:
M3@>*D;3&</S%ANW=9]G>SQ"D$Q'_OPW''L$MHZ$E 6-]*)806JY_J>EXC\+/
MRZS-;F1AF0__H>5UCO=WN,XS+)OLBVN **42 ,[V=_4S."Z"9/0?<!Y_@GYN
M._?SJ!9%7+]0DO5+F).*>AUL*OX65=1[X/<%<%PJT1(!NG$OJC?ED,S>AF\<
M>U5JE;TJ:]O-^:6+ 3BEY<.K^Y;+U4,CBCZ)ONV,JZ]2L=Q@L<Y\#G:N138$
MQ/"[O*QE(2T[BNO/T_N),0V_P[][C>G[J$NQ!($#E\T\22B&.,]R=Z,7Z7R4
MM0S,T:G(8*%OUVG95"9 )3K&3K&$?A"ZR<"UW,WU;\+$"D1M+HR?!R**=CH*
MKW(MG$ G9$4&X"#8N@'G>$=UB,\-?-UKY8!.D.)P <RK\_&9B-HQ 0VY;B65
MM64E";5'-*X=!?T:F%>+F596X,9C:_LZ7V(Z.)^@^#EUTTRH YA[72#8E%VC
MT3*2\TD_U'^!1/4RT\E_3LN%F!UU6!+6)M2\,; TQO8O,NW<X?6-9#@5LH6D
MU;B=[/2_[ /&3*I+DU$H;@R?<9WAY%\.E*6Z[;? <36,ZV+H#2FG::"(^&]F
MH2%@=T*&E$V:O6%WC T$[N">76"Y_BMP7,5+Z$)42N6OAOX!U4ARR+CI\\GN
M,V M$+$@ )SM[*_#YOEFK)7&TI:(,GI@NW9(,%#T,#98VQL2V:K8D.0XM".5
M$NJQD(3,A._$<HVG6$),09QBVT#=&:M,IGK(ZI#V% +L:@!.]T12D>+J89*L
M-G#+\(T!+&W)T4TQ!6/45R6X#KHY5O0_0P)P'?S]2D@&+J4Q+6O7(_@'_0$>
MWZ^P<C$5F6=-11+G>!XO4N VKI\&\[&F?&C5;OU&U,8X\R98]N%PSDR,5+\1
MP3/4OPEA::?/P$*Z;AZ/X$=)P'5PB@S V<@3^64=TAF0"W&I_B<BJYL"R/AX
M38IK-\;BVDP$>H,9<<9.)7)53UK.&]=_"M?T"%\+LP$6+]Y:&7@K/+.>H?M,
MN?I W)-Q/3/1BB(4,V2/E$,.--/>3PPW?Q=U+PI/V5266T-_@ *U)CIKV=YQ
M1@-)'',FZ;4MC(-4AE0BX .?,8>6ECG^!NKH$X22&MOW+';]RTT$(]+9_:G6
MD6!:?-M\V!4U8>H:6F33]HZU7!\=JIZ ^[@48\D*F@[2UJW%6Z"OI>5B:7*J
MX9 QR$83$2  G.VTIWT9-I-704+P\VA"^T%').](W>W?ORJ*  A>,X(A%,Q!
M$ .3$$4[%Q*NFV$3_QA]$T:U'HK&]O=N*9Z<'AND[H,E"P+ ^7YO/".5FAI1
M]%^@IA!/THI]X]O$ 8#WD66#FV#X^4%TS4(="*2EP]&%_WX&6CM'%?TD^-M/
MI+A^'(UI63M92FBS8$[9,1;?:%%[;431;L?/@?\?/V]1A+)X*"#TGXY/YGCI
MEZ)]B>PA.,\G$6S"<\=X#&Q)1&WMSA5MXL5XWV7]8;BF3WE9:!AU2=ZGL:AH
MY\$U'AKT-^I%!N"\C_&#C#0&S-+UJET[OC"!=>!6?+90-A5][FG/X3X QO.]
M+=AZ344'<,?UI>S^Z.?#?#LXD %765M6-FBTC( U7--\SJ ,LXX1,D$O0D<J
MZJ@I+,6+*&%M;-TGE293+=1)<?+/0E*7#9';U$;F-I5_ G[^M>62R9:=_<'4
M!M(;+;715OJ[[@_^VTF-+4.G.-[1D,Q?R[5P6CB(4_RBS8Q)]:7E>%=;;FY\
MJJ&Y$EVV1.1O93Y 3&!L8%E=JB$[*N6022G'/Q?NWV,6<R[;&$ WLF^."\K0
MRB^T;/\FF!LS$<@5$2  G"(#<$IH&0:^T8>-4[\1(V)(X\5D"Q-&I&%'$M4Z
M?/=1E 6$S 5,EAF(4PPU__>QQ+QZ?RFN5@@ Y_L!.' /CZ3E<TR79'DQ"W9R
MK1&8C^K+R,""<?H=EJS$*C4+*?<0!^-C\>0X? .-]PU^'XD;8]3W0:89QC3^
MCE;643DY&N,;_STFV_"9/Y(2ZG3X>1;TW\!W_24BJX\CD!/I6,"!EN!$F#[/
M&Q%%_;.DJ+/A>^NHY3:"-\B\"6*#A(2NI3 6-"%CZ^G&$.E9?#U&OXS(^KL0
MD[=%$IH9,)VBH@9P))B+6((7@_L*SZ2)E#78WCVA'TY=TF M@37$8*"O/AOF
MXV\EQH9] H[O< "YV,3=\9S>@'._,9I0CPYBO*&6'3IIT3V/K%_'2F%#+5#_
M'H*15+LH7C.V/;7\1/L^C9#2&3/(+L:L99&42VHMQS_'0E%3QW\O!*535+#8
M0)#%]3^%CE;:5QF8B,\A_1&\V!;@IJWA?1H_FTAHPVVX_GF0Q*/-])I E5(Y
M_GH8WUM3CC?=2&>KL%Q&3(+O2!DSI-NTF:3'L3;9TT+PSO&OH.Y4C,W4' IA
M8RK(G?\,.CJR76VYY,BMEQ2*)@"<0@$XV]!&CI10TP'.Z134R*&;Q*\*OQ9J
M W1_5%%G(&,HNO?8/06 LWW #15.'%$;VX*J_GD1L:LV@QO,::6%O?E6/V'L
M&.UF%+B$XV0$9FAI$;/.W:&U%8% !'VPE)!JF3 'E <@'OX=9;H%35\3.VT'
M1I&.KB0H(OX1:D_!9OYT"BZAADHB$6@[8 2$*6 VA(.$S-DLU);O$9Q## P]
MI:1BI+1%R9L <'8LV?UK.<31;K#6=WRB6[LS,E/+A];N1L'>A'JT)*MGPKA>
MRBRMJ4[8*KX>% N0TU9B]B#JJI0$K<P2&C*!HY7)HU'HG++U6'E;F-<+>)[I
M#TMQ[2*\;EX*+O*#0C5D&""8@:"$Y?HG0;\%DKBW.;O$#XM@,5S30Z:=N\AT
MO.-3:3(*P1O4.4$ :WL8&32I=4G<3/LGFV[^'I[(KPG0/=D(]P#+OV8;\W*'
MH46ZF 7?#7)BK%# S\X>@."79?L74I%OUU]FAD/8& &H=3!/EEN.=W_*\6=,
MA=@P,NOZ(' I@D  .($!<$:,V+6L4JMDPIS:+,9\T99Q(3Y/ #@!!'"0&:&,
M'HAQU495YV4MK<66$./\8P"*]BC.!]3J8?:RJ-NC[T?95Q2\V7&V R:&T6$U
M_='"MBQ>/1:%G5$/*H+.2:Q$ZQ7IJT#.#HFRLL_2/Y;8M5T!B>)IZ$H2D:L&
M4;'B@#,XI,K1>[!QTG[)K.FI,'N8$S*/SZ'7$6!$C3$4"0\J$-=U 9P,!;C1
M20SW M1!#9E]L![04D"V'MS#3 ;H_J 88J\5UW#*DHUK/Z-BP,S*/C Z3,C^
M1:<]U"B+*OHKW!TSS.O%:HBC-VDL*<D9C&T9-('Z$#5TG+'29'^KT9MLVO[%
MEIM_A;,*<B$HG6IF95/HLN/_%L5H4?,&2Z$0C/F*V]2V9?*EF,RCX+'I>!.1
MA</ D/PG 6):-)FN]Y3E^A=::2]EN&28F 7;@N' N$/,G) AO="ARFC('0RQ
M]1NXIZ^&2-C8XV63B^#:,I:3U5#WR9A%(B("!( 3&  'WPCAIJ)BI,3%;E%C
M9"%_.Y85 $[P !SZIE-.CI;DZGHJE"MK'Q2I77PSHYEKCV%9$\R%B3U1=+FR
M=H\^";5'R0 ]TKZBOBQQH\G/B%I:4MA=5H=0!AILL#&)Y'&_IAUB?R-U(I'U
M?\'U7=!#T2:4#ZL91O6<Z"8^^+:R"/S"FG$L ]YH^678$[(V"^HEJ&T1&S)Z
M',9KOX"6P'5= (<_][98#_KQ]0"3;"RUDN+)L_"<J#9.T<0>K.%Q[95(7)O9
M)S&AQP!<'P.DPX3@N<1>$KW ]88VAGN]T%N@KZ$@CJ*GR^4Q0_OWGQ@-.G ?
MV(:6R9;M34C9_GS3]NXSW?S'(1$L;J+..HZ'FC=7HF#QU+/)$!0L1M;1CMRS
M:9G5/8PTJ8+/KH=^I>7DWPG0_6E!D,YR_;_"SZ?7I;.CQ"S8+L"3"AM;9[<H
M5-B8EE/E'^/"QDUF"(2-\5HLQ_LS_'PR"AHCX"E&7@ X 0)P-F^P%+6*NV+=
M!^>VN*"BEHIZ#S(QJ+Z)$#'>[OC&L@ 4\64"P)1Z7TR;VPT<*%D$\78+G.LY
MJ'V!&C98VL#?+'<*N$%U&>!^161U# HC0\S=!,?'*2N( 1+;LS8@2+:64^=?
M@N-=F.C#Y]4C>-/K@-I>O!0LX(WI:DF5R0.0,161M2<BS#I\0\@!G#8MG.48
MM[&$>BK:IR.S0  X@0-POKG!_,1$6XHGQW-MN#LE%MLKBZ2<ZG5DO.$S<0O7
MNN)N _0(GB]JET&\_0;75HFMDZWA9^SIS?Q9=X54J1^.@&]ON:JGV(47H*7F
MD_ZFZ_T<$K9[.5-E35@$BPTG_R0*%AN.-RG50$9MCV#QMS7Z&0[9JVX^&0G?
MTVBZ^85!*BNSG/Q2T\D_C??&;"0U8A9L!X##R^@H$\?.'F YY&B(@5]Q$"<<
MPL9.?B7$]/-P/3>8:7(LEEB*D1< 3A !'"H"JV@GP'E=#N>X(,J$5PNSH5>T
MVR%!FM)S6'6\5R4DO@+ V>9&[>/EY*DQ1;\';9WY9KF8-K;+(G'M21K_LGHJ
M@B?=X9PWEQ5U(L4<V3 C62E%5*XY$+4*X/PR%,14M#>WLX0B1]D9S-WF"G3)
M0@'E6*)F1,_]X-IHJ4VPG8O:$C)D>97)^B%XG2Q!Z0PWKV(JC= 6P-A>BR S
M,I$$@!,2  ?F)SYO(LJX@921JFAS.#-O46'V"?_3W\1SZ@OK%7TN,K"[J!N"
M-Z@UA$ V//-NXB\46@M<HMV9SHJP7JCW1&3]3+@'AU!+<=$Z\7U#YLF=4=?#
M<EOW3M%R"1]9)%\&VCJ<"K'ZK5RP^#4#W98:R>3O(UC\;0U+KVKAWDW STR3
M$[BS56L@W*C8.:Z"\48!YFL,FQS&2LF*6:B6E.(YHJ N9<#,(I'ILXETU!Q2
MCN.Z93^*6:/')F9(%.-[QM5DE_8:]Z_' 'X?$S8F;<+&KW)AXQ8>BT%EXFQ"
M+1SHBRR;.$8CV0?O)<2\H$D* "=0 $[9T-$R.G3 ><V#C=9#D<*\4<=-CX^N
M(.@8(NVK5J!5L0!PMJE1US'\3&JAK6AO09Q]5F![X"W'M85K\?R+BMY"[*/-
M.2V5*OSKAIVP) &3(NI4HZB_@GXO)DP<R&S]!FOAMI*:+"\'^(*Q=_1+T$$-
MR]AH,HHE6P'2JOBNAD!;V>#J> 3=P63MKBX"VFS9-]&R1%8*XJ P-F="!&J,
M!8#S'?L$><P@QL319\,Y_IT+G1>X#%5?C#&'3 [*3 V _A+=5Z ;HJ*YN*\(
M?^G4-ZP7<?5Y.%X)>ZN?H :;V(5W8IO:L+8WZL%8C=Z1ENM?95&A7TS< JM]
MXYLN!6]6(QL"!8NQ;&I+P>+MU[S9&IY 2C&9G7 IZ6XZI Z^\S;3S2^C(K!V
MT2?MC*&$+ LG?[OI>L?4_C<Y+TX0!X$;#LCT2CED8/W<UA%H<XWL(</-'=S6
MI[BY6BSY,1IS.NHZ377)$ 18$-!I?TSIJ\+&O)SJ M/Q'K7<_"H:BT%EXC =
MG+6\G/)*H]$[J@[NI2BE$@!.X "<2JV2@B:RVH#N/!ULK[RU$I0LM9-6M#_%
MAB3'49HXU0P1 ,YW-NZL(C%FQ)5PG9]#7U<DU/\6IL5#F5U_1'<L!&^H&U-Q
MO$6F>A@(XI17ZL-1!R."SC1Q^L;X-4Z#;_ZZ]3F[+G4%"D7#-=T+\_G<2%PS
M:;F ,FX@+9D*L%/1UA+;B*+50)R=&65N,ET-P,ER%LY'$ .7X7S#>8?S3P X
MX0%P$,S%<JJHG/PQ9PM^QH!<U2_@?7H'8N[<7O#<H$R.H@"_O[TQYS_M9#CW
MZ^'X4I&\4.A4+1RFI01K)3SS\=D@=N&=V# 1-NW<#RW;/\.T\_=!HK8AX';(
M.4B:-]&DT_4O-VURN.42!9-."MR0]@8GF* Q?,=XTR676P[JRN0_#4C2CN>8
M,YS\PT::3#WJ E)>VYX 5SLW9-%,_3_2.W4>&8C C>5Z1R(X!_?^%,/US_YO
M=_Q?0O\%]!FI1F]*O4L.GI8F^TWJ**MTPIA!""RA)D[*)H? ??T#Q. '-!:#
M"X;F.5-KD^%X]YNV/PL!LLD.$8YE L )%("#[CB4-AY7SV)O'&GRWZDUXQ$V
M%FNII2N[+]W:,_D-,X#38X3>ISN^F54T"^+[=@;<%(UX\08.WER!X(T4K]Z_
MI)/U;K:AE=)X2TSH3AVK$IC@JF?P!'=1]*NE:)11Q%EJ;\+QKQ&F'S6!NHU@
M8K7YVD)E'8LE8;&X;L \N@#&\ODN"."TE49D::DGS#><=SC_!( 3'@"'ECO"
M6L 8)-I\N%?OPWJPJ9" .!-]5R\L'UH]%DME@R"@C2+QG!'Z%#SSEG:A4LO-
M6C@*M:5?@GL^W(.(77@GMGJ[=:392+5OKC8=[U^\!"C(VC>K(6E^ [5\+-N?
M"<G]WNTA6/R=0%AC5H7OGF,Z^3LMQU\,R:X7F'OF>@M0R'C2?#(4G;6*P2X:
MF4#(F*G/D-V0(4:9-BXYU'*(D4J3&7"/&RP[=R&*1T._$7Z_M:W#M?P-8N F
M^._7P>^_9]HTY$R(B6G&/'*8D28Z]/W@\P<A<Z;='HEMPL:-9"C$W4F6"^?C
M^NCFMC+@<RIG.-[+<#__-*71/PF91F+E% !.H!@X\>1@ZL!!Q1O5?Q2 @=-,
M2WX4[6WX_G-0P+C=D\\0 SC(H$)154E)(@#W2!'9WZZCF]>X=B,MFY+5,='!
M57L6^SI!;;)E[= (.J<P)@XFN5]@*066@L%_?P>NY7$8QZNIOH&B'[$KTN,K
MVJ_DKPA;:3D5?-;F(D@HT;E:D!(F9#U]"'U5E#'V<@4"*A_%$AN<=T'3PA$
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M^X/VV.T6 US8^+A&TA?B;QS,JY,01(+O?SOP@N"N_S'<]^<-Q_\=LG#$RBD
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M17I^+R4K?Z<Q/$+!X0_HX'=D=P;%/0[ H0,SP)N^=)BGP_+9]+U_#?'9.CL
MI#^(\&]9_68Z5S\B675BVW8$D(IW2.N%%0"$RZEO++-/ 5SX"_5[R-_/Y*!W
M;>W.0DX9@K_%G/I= (8</)14MXS@<R<@_QZ"PI2L-:>D_%? 6$H G)X#X-#X
MCDAEN?_?G<HJ?P_13LMHG[PX79T?WT]2JB,'X-!X!'G,OI49M8'&>W5(S)O
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M\F1*5OY*-GB7#ED?!RD*7AEOKI%VL!F_C: GG5.F]:\9(_4_J'M3#WH:@(,
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MU6D#]E,S7)!TVXWK]J3VK1^<RFFG<1T,7HDFE/D T&@#K75/4E V*ZJ"LPF
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M]RF,&>!-XP*V:[D 10!H]"ZN)]^!G3X* +98^ _-WP?(;M.A>P0&74O"PDD
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MI<DM-I)_FS26TY%*1)^_9>-J^Y?1/U^YUKC0[^6&[5]"__\Y9+\@.]5RO2,
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M,Y:'6WJ*I\'$&L QG-+3ANU=;C9[1TV8V;E[.<X)*NX8K<$N1HLWV71*<Q,
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M E0"^$6Z&1,<SVF_XRR<=_GZC7I>E]/:7\#TIQ3MJ$Q^5&U%K;%%[ )MVB_
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MR!A'M+[0G\R0PA[H[W;#AZ<W%],"03_$+6F?NY9^ZTFP $2PDY0*,TS#Y06
MF5).,_%^Z KQVW(#< #65N5&#:7OVB>=T^?@F6C/^#3B5*KU2HMKSZ),//7I
M9%R0Q"+=!7W(J]6562TK,=TT_5'^OE\EUF(BK"U\K^.21F^NJM%WKJIIW(:S
M]LH,P$%98;>T@)7G3D"Y:L/Q[C!M[\BFEL[=C9^MVKXLV1+-';M8MM=DN?[9
MC-5BQUYPMCVL#N;=:S877</I;! A<<Q\R@EV!#/*</WCPDI4-&=A5;?8IN71
MOK3(<DM/8AV(M+R> .! %T/[ ]@&4E;5V NWNPR!+U(WMAN>!J,!MS92OG$0
MF D(<A$X4[_N)ELBR>KJ"'5O_OL@K&CW4G].J1Q2OX<DUVW4A4:/ '#6 S20
M;D:'NXOH-Q\'W9H'%/'50%&T(@^ZWJ&_GZ%U.I_F[#+Z/*U*T0_!_%77%.JA
M[0)6#=+%D X%PRTR@(O^N<)@\NE=:)TW@*T% (C\9B9]YR7DT_,YHRQ"4%+U
MF1Z-PM*UYE4Q;0P5_=T1J4\AVV*C;^<9"ZFR9K3,Q$@9>,/F701D"4N-"(%7
M]>?0(>N*ZF7E!N" 18J+".P!K!2YHD/_Z^V8I%+!/J2^/)]6U!MICYO,-+!"
MUEUT3!PV7G4[I 9KWR-?.(LS(<7Z2YZ1G^OG9_+ZGF GQ[C:V28!. M,I_1/
M"N;>24*Y:LOVYC4YWE0FRMH<#"A+!DY+YW<!4D%@&@%L BH&0:_D>>KSK:9=
M/-6R.[]7(5J\ !Q6V2RH,68%XTW'N\IR_8_"2D^Q]:TB[4U+J9\O6HY_H1#&
M+G\ APYR_V'"IG1H@K I!9BCN\.0@Q_FNB.%1#L4HH74GV,Q'NP IZC7@NE"
M_]M+G!71$8IKQH&!0\%W7ITNY1MTI-0( .?K@WE\/P ,EB.OJ OX;70QQB .
M?&T-!W$6LW+<BO88*VO+Q!JU"T/18X",^BRD"'UNZLQ43G-XVMAO\.^!R4-^
M?3UG(=&8L^][)^*@#F/?QD6%GZ5^PA];R;^/I.?>&^ 4P*B-FO%L8R730)(+
M]2'32'^#OG-9S-/GA/VO?1*^G_1;D!H!O20!X'Q=:^T-\!-@+H!;!GZ%Y;!?
MC\F<K@PKP3&6RVP)E8/ ) 5H&U$#\X\)QX/IQ5B)ZA*Q]I)H^A*L(7K__01^
MQ:N=E1F @THO"+X=?TD"TBI\RRG-!3OE,#<8>GASL'59!MN\Y/-$QTM,R6=4
M!Z//:XSFX+@)=L=P$1+'S*=F!-)X6B\3G6(!0M/0++(<?UF,67?P>?1OH>7Z
M5XC2]#V"@;,8@2DK,:RH<R19/;GK#=5HZ+DIR&7!G:)?3K\_EVG+R-HS].^\
MNIZ(ZVHN>AH7QD:)!>&*>C2T45)TT!< SM<#.#C(04<CG=,/IX/=7 [*M<4$
ME/NJ>?:Y[P%L6L6!CH]X%;1W.3MA$4NY4O0W*< -#7^S5#&F][*(LWC>"[5G
MF%CR\I")HF]*=:G-!U3A&7FE*@"ZV MXZN*XC4T1Q*U^Y;#"X#" U:Y(A4"8
M$"].GK4SGU=8>I^+%!<!X&P(^XRLMG:+JJR^,RXI4GF . RXCL.<>AQ(72A!
M!TO1CZG,C1H39;#-M-+ T@R![[O"?5:LO\19^'[["RX$,[G"Q+"D>+FQ/1S_
M!9;^XOH?)$!K!4'=C983_'"R$PPVS@CZE6,PA2![HNTW&XYWF^F47@JU?V(]
M+ZL-I_0X&$.&'4Q#"I@(B>/5&EN#;P'$,68'><L-CK <[VJ+:>&4_F$YI==H
M[MYGC)P0Q/7CH7?E+S=<_QW:HZZ>Z!;W$[-8Y@".HGU,+]M7Z?,)"K+F2XK^
MQRXW.C2F<Q0DRMJM]/SWHKQI6H$>ATH!L;I<"@_P7OP">GUM-9^;,GG=@*@M
M-% $@+,!;6!=JFK'AJTKL_J>$@/MF,\OC@BT%/9_^04+HO5;H&4 EEPZIV['
M@]D-3K& /A 3()>U8VE]WQYE4"YL4X-]'7/W@80J8FMU<#:CF'$9 CCKF#A(
M"X8>2#JO3F7,!"9HO [,C%QX5@I9.)> '8E^?H4H>]<S<.2&&K VN'CQDZGX
MI)L)^V;K9P4K*2YK\R2E<!*]/W9EA2FB3,_K @#GM;""D/]) K16T+]K<!N/
M]*EQK4&J'(,II(O0O)P9B@*7WDP @+,*U<$,NW@V?5I6<WN-"(GCU5I;@]X
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M^/SPN;<9L ;FH:)>EL3](HVJ8N&^NXR#YWZ$9Z:7:%W?)"GZ:1( WPC$L06
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MX1R$ZO0T!RJ_@ TU;>\0JNOUAN,]3<^/2Z!?ON"@FNL]0<\3C#-6K'>S!
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M')=,@> JUBTPH*C>-X8.\9J0#1,5^^M]&G^/0]\$H#A?4P6 LY&L"6,+,.8
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M0Y08BQ'JS,K!Q.'9LUK8UG$-^1)%%%%$Z>;2!\P<+B ZHGX@@!;.RJFNVP'
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M3RU3XM4@J#W=AO9]>A^\](J]PX6IW@%#O(Z>]4.9]XC*L&/'II3H(DF<.6(
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M!"H<>[VILD@%!:?XI#1 @6@K@0-E1KJIPQO)4YYRM,]C4%P_0;_CY*I5!,[
M:$@JR*'8;31VGO4-Z=RI8PAN[^I]I2'UYV5*? ).V7J&C^Q>,$S;(Y?6#BB^
MGCMW_ R:%W?XX[&Y_;C&<_V//X#/2X^V'""SBY%W(:3>&/#6A<Z<!S!<5OFD
MSA(9T@'OK$'J4,^8:KM'EG_*/DWFR/#JNR''U_MO@O"@J5"/; V!(T^O%?5.
M_W1_59//\SS]%L#(1)ZX]O1^VN+U57T0#A*D >N%?KA-E&D5R3/!"+4#\I@T
M[1VRA< !.1E2[\O#?1ZR4H8Z4UM)#Y'(Z-[-)G 0XD(&NT^0O>/O(8T]:V.)
M$OL;]GH8SL@/U\%+3Q?,:7B#%,.; WG"$&9+XR_@$1$;6TG6M%@\XB/V<9#J
M7ZJH,Y$X.+A_K(^7^+A=KB OQ'<A 7,P-/(H:M\K:/U?*@^-X#F3C;&DQ-]#
M_8(1]2J2J5A3@[2>^"&9S4MTC!R*^U)_D2X1",7/]D@:N6^OI/9;%0A+(C#M
MKZF?(,2-ZO<\"!V$K>'0 \0,0N9]DN=#^O_G\E!'4:]!;KP]23>7(5H5E7L%
MJ"_\=OK,UU57X7W=(C$52:P;)W!2HI=1YTPD(^L:,L@?];UP\NSZXLP',AFN
MY9P,+XOMPS3P,PQRZ7%AB\FZ+5)D?"^FSSV//#J<L'A;4LR_?0OA="L,VWV1
MVO4?FN7\A0SPN^CGZ^EO%]%[SB6C_!2MSAFO)],C#;M^Z-24Z ?C'->R>^V?
MCS</B4*4'V/("^VJWZ^F+AU/F,X/$I:8EK#=6;J76!DYD^XTT"ZFLY3&TZ;\
M.>O\,#,>2UOD7<UR?TMM=M;DI!B-MF5ZA0D<)G"8P-GE"!S/N'Q%>F%(;QPD
MGE3'=1\P*NS5-S<\<:0G$P@/1?V%/.'T/"2:6\?ULA\5>;(\ISL24F]R&6<"
MQUO;O%/RSZ17CA=>LPAD%T*(L%X4M"0'#!,X3. P@9-+!$ZA3%0[3-M#AO*$
MHJ-EXNQ0[,( R'#2-:B<*[;R0,EDJ9TWPE,485K(MR1#NL.Q4[VDSK']6N+Y
MM$-$QA4%0Z,.]$*%U8MD.*#GZ?A%R\*DVD+@2/+C#>F1I:C7RQ0"D>KC43\9
MLMRL=97ZCO0V2>)(TBU^EO26#*O7R<.,<.QYJML:W]-TR:8DR]C+X>T,S]4=
M$S@R5!_>7W.DQV D-A9>8'["YK=\SZ+Z%A$XR >CF^)PW1;G&=YM5,ORS#@$
MV;#!L#+/D$%=J]4V5":L#?UG+A*;72+'S11%"*^B>IZH6V(^O??O6Y+52B\*
M]IS8-@GM!@-)B&UG*<EMFI6^E(SO68;E3(4'!1+2(@P)A$V-*?KX(4JE(#X0
MMB2]H$3^7AN]*?Q*$CE4+]1O&FYM Z$S3T2,I#B0?AZE68X!(LLPW:MI3-V+
M<#[=E+ER.$?.5D)M\Q:2A(-@I7:+CI\MRIA>80*'"1PF<'9! J?>5]10S]=\
M<N2BLM#(T8B[]SUQ.GWOA,*+VT%D'@6$.'AN_<UV<_==^3_"[2FED9'#Y"EO
M)]Z^E6,$3L8W:*"LK_/#'5Z0(0Z*:D&QE\8&$SA,X#"!DY\$3F1<D;P.7%%'
M^NOHG1YQ(\.D5GODC<QSD\EB.[L^8?25],0!:0 B1XDG<3,4PM':4FG4MS1<
M/<D+)8H_Z>7=DKI7?1;K6>^'L'Y"97C=&Q?0NT8>6SSXT)"_KA8VV7\X2-GD
MB>/?%(;Q(@DOA+XA-!MK-HT]Y+R!?@K=0UZV@;5KQP3.YWZ.O"4R+(O:';ES
M?!+H,W]/<%M$X,A$KP@5L9Q)9*0OD-<];PD'R2LCT;#=ZVJ0)+>VH8J,[QX@
MIZ988F#"$B,,6YQ*[UNH6YF_D2QGPWHS6;.>VFXUM<D*>)$8EO.\;CM/D-RG
M6^F%ABV3#T_6S?3AN.'I1%/LHZ7>R"EW[VQ"6RRZ@MB1N9128@C:)6$YTVB,
MF88IKC/,S)]T$PFQ,Z]YB<'EU>2XU6J#3S;NBM>3OZJ;[I63ZYP?3DH*SH'#
M! X3.$S@[*H$SHYB^:' _1A*HDQ<VIG7C%.;2\.##"F9\%>)OQOTW+_K6U''
M=3*W1:AZ+.941U^=G4<$SLZ,]Q=)L;\[B.MRP]$1TACH,[Q5>R43.$S@,(&3
M=0)'7@^.\0BC'FLH0I5P"ZAW>0"M]=GR1&DNH2,3?M/^0WI6<2@ZVKOBNH4A
MG#1WX+T#HA[MZB>\_XCVCJ\Z67_\TDN6'+\9\QQZF)^/K<4')%ZX$XTU6I_D
M#9,>.?5T,!0_:8<?V)K \2YG>+/$2VK_HA]N]9C,B^.100_[-VRM],FG%H50
M[8&P(R/9<*!NBUG2>-]B;.:35\I*D#.&+:[0ZIS),EEM7?T0)*5%_A+==F_7
MS<Q2/W_)6B9OI*RG-EM);?,J"!O#3%]MR"NVG=/EU=MSTT=HR8;*2=X5[0.0
M+PD>*>V19#AO(40APL/&+1)%$^K$GA.M;P;BNO.:I(AK=OH8W1(UNNF>1>UX
M*4*LO/ J=TMXU2[HG8-01<UT+5P/+W,DS11%!0PF<)C 80)GUR5P,CXI\K4T
M)A7U5KA@0^EO:_A,6TZ.<4+9O:(J+ U;,JJH3*O]^>.THHZHVWV!D#H3MWDT
M(RGKKDO@> 3+IT%X98746P.AZ-E(--K:6W*8P&$"APF<+!,XV*^H/XKZ5RNT
MYNG!T/\#  #__^Q="9@4U;4>,,I4=P_@0E1$F:YJ0$/$99RIJ@$5=]&H*%3U
M@!"-B>ASC4N4Z:J14:-QB9IH3)Y[-$:-)NY+W.(2-:*X;S&X:Q!1$&2;F:[N
M>N<_]XZB#^AM>F9ZN/5]YZM9NFNY]]Q[S_GO.?\Q+XCH]AT1W7J%Y'.29209
MDK"72#82M[Z(ZM;;FF[=J,4;)P\=6A>I&CUZ@ZJJJOY5>1XQH_'[6MQNB,;-
M:73-JTGFDBPEZ>C!=\.]%Y)\$#&L*VL,>^+@;1J'#ZX=/Y@>N5]5@<=&"7-@
MS4A[Z^A(:\^H8?V6KOL>R5/1N/WCU7YAS)@HW?=(^NQC='Z1].!>S;!OH.\\
M3+^_06W^'YSI]Q=([J=^^".?=>M]Z KN,3!A6H.WMFK7^F"MK6'_\:UA]836
M<*#C!4F2.UT_\Z7K95:XJ4R6SF&%R.*DEWV+Y,%D*O.+22WA#I/]]-Y)+SS?
M366?<;WL>_29E17T/ETMZ,L,24#207W;1OW\*;77"\F6+/I\5I,?'.BTM&\[
MI37<I$H=!1\82\[IX2#'"[=P4^%N22]S,LFUKA<\D/0S+U,;?TAM_Z5L_T#V
M1[8/ZQR]7S:=]+-/)OWP?YI.#K<\O#4<3//-]Y2VE/_01MI;1'3S3%H0/N7%
MNC0IW#@H3=IIT7LPJMO-M-!-J!Y9K^?[WH-KMQ],W_\?DG^2S"=9GL?S/AW5
MS9DUB0:[.MXX7!HQI1^;CHD.-.Q$;$3C+O0NOZ+^>#W7L]#B_A6]\W_IY[MC
MAME4TOV'V5HL8;ETS3_1_5^B:WY60-^1L6G"X RZ0^@9E]![?T+R !DPAQ73
M!]7#&^+TS$=$XN;U9!3]BZZ[J+#WM0I\7[/S.\6.DY#>]W-Z]U?IG?\239C3
M-M3K!DD#NE\W3QG]M(0Y#(9CS+!.P/@KT8A>2?WP#)TOIW<[/):H']T#[\1'
M9,NQ0ZMU>RKIQ)6:F!<^*Y->K*H/Q;69;LV)LOZ:QT9KZ[>7;590N\6&6]O0
M-:;3F/^-G =7]-9Q+P7.[=7TO'M$1]=OMBDY0(4X5S1^#B4=NR7ZC;.<:\R]
M2)^].):PG6B\8;NJVO'57:UST=K&[4G??D;W^P/)<SF==YH'2)Z.)NQKHHG&
MZ9I1OV6N\5I%[ZX-L[?0:JUD)&[?V07K;D^L]1]A?:+G_ZEF6&-CB9V'Y-O&
M-;7D5!OV+ZCO'V>G6#>7Y7C6MHAA_AUK/7UOW^I1#?$NZ_ AXV/<%_0.U(_G
MT+U>)EF0Y]A;79N*,6A8:0E(?%?2WYEWBNF_0%[KJ8C1.&-#?<]!P\AFJ*IR
MULOWM0<D&@V-[!3J@U_3W/H/NM;B G2F\_[MTN9KXSYBX9_;^?^B#0IYQW;9
M]G/I.K^##;G)-G6;;S)J;$TQ75L*@$-SVI-8 ZEM3B?=N$73S;>E74)VJ?EE
MQ+#O)-T]">TG 9W\ 9RJ,.Q7-R-<GQRK:M</]R.GZRIR-/]-YP72V:\49W$%
MR?RDEWV3G,:_TCN<1;]?0C__G<X ;[Y@QWG=!7#:2!92^WQ ;3+;\8)[Z/<K
MF_Q,:U-+.,/U@_V<EG#;IEGA4*<UC"GWMXB#QA+&T<2?AX.3S6TC'3_<G=IY
MNIO*G.1ZZ7.27G"UZP7WTM^>I[9_!_U!LIPDW3?!F\P7I&__27J9&YSF8/+4
MF>&&SDFA!J!+*4LW."W#=]Z<#,@4%C$XQ\6*-$"" HV"E27=T["^H,7M#OKY
M9)(]JVMS+60*P.E" *>=/K\XRI^UY]&S?$Q_*[O0_=Z"HT.&]0U:W)Q<55>W
M?C< .!(LY!W#A5)?\GMF;A=['MHIRD8K&YS% #A+97__DPRWTV(CK&UJMF[8
MN"HQ84 W3QG]8T;C#V.&E:0^N)">Z5^E[H)J8C?V87+.SJ)QM8MXI_'?ZVX@
MIT@ IUT""XORT@N C[KU*8VS!:Q/PNDHM,WH.^9'=)Y-\]$ET43#/NQT"%W(
M?U>\<  GTSEGB[F7QKW>/>->RMRH85Y0DVBTH?O"B50 3MX CFY.HO>YN90U
ME]<=X3QG"XQT6%[B?=]"E 3 :VV$9?+<5X$ #OH+M@KUQ8G01;K7AT5$HF3E
MO-$FYAWS(WK6?]/Y99Z/X_8S+$*?7F. 0FQZ?,'KB)BS"@&):,ZRGZ?S[TE7
M#^!Q)];=O.=GFF.V!0 !((*N\VH>]A;NVR;TC>:ZN/6B%K<>HWGY$=XTH/YA
MP;HAYJXYB!*2&Y%+Y3J;2T<!(KW FR+4'W2].MX8*7)-+0W ,9_ =S3#.H'>
M\2+ZWE])1QZ5_?@4?>XR;'#0^6S,^X4!.-+QA%-%3N8NR9;TKQP_>%*"'AT5
MYC"VDRQU_<S'='Z-!$#4?!E-U%%A$45=+5\E_>P[)$^10WU%TL\<[WK! 4Y+
M6'=H:S@,43< ;B8<'PYP;@W7JU)'T5$XB#"9T1I&J#TW.N2T%<.<YO '4YI#
MVVT)7=+!9FKWJY)>\ CUP3L"Y.B3D6%I!F_\[(,"3 UWF3$C7-]QH%MA/Z4I
MY3^BM?6;D5%\:@2.NUCDBQ,V) IR3CMH4?^RQ'N^3XOVGVF!/Z8Z4;^KIM=M
MI0"<;@-PE@&<B(I0WY>I[Y^3AD59A0SJ1V/8C<).E&%-Z#8 1QB^\\D ?3<J
M#-!\G_DYM&E4A$)_)!V@8H".0#H6[\+A1A0"= 9&8W<#.&18CJ/W.#T:M_Y"
M[?=FB0!.1AK2'R%$G]IWXI#1XV.%@A$]". LDY][C^;1UW/J@\&.QBO4?_^.
M\KQ3%*"7E5$X:+=[:$S\&#O'0A?RWQ4O L!),PA)\PX<83E7S.XNP2XUHBT!
M>O"[%N!H*0#'W@)CBZYQ76EK+H/12PK<K%DAG[N$^YK/T_CZC9:H=^%H#QQF
M;U2)  [T2#/LXWBNPSN)]2 H#!#CR+<V38 ;  F>I>>]3]A"UN5P]J5<2>]\
M*_WM(=R+?I\KYZIE!=YK#GWW*CH?C;8G#Z;@R$^MUC(!^-/X?5V"++E I$#J
MV:<,2AFT5AO6+^GW63P'H&](Z.\M&*/T]VMI'#T@P:'YLEUSM>E\$=E"U]'-
M_31]W%95XWGCH*AUIR0 AT$<ZZ)(POH9-B3Y/;%!HMM_P'H$_:TQ&B;2_['9
M^G3A (X\G%3']N1L'>OZP?6NGYTCHS8J,56H0T8VK.BCT0WY@%D=\OWGD;Q)
M??HX]>U-;DOF0OKY2*<YO:LSLRTQ=>;B#96K6UY QSDFC#G-X1!$."'2R?4Z
MCG;]]'E)+[C%]8(GDE[F+1GQME3V75_0P79ZM]GTCE<D6\*?34F%8Y0V=.\!
M0TB+VPXM8/]+"\+-Q0KO$HB=FK9\C#LLL.S\\TZ*=1?=_[:"[TM&$"V^S;2H
M'4B.R!CD62L I]L '#*L[&?$[A493X9U*3D5EY1=T#YDM$42]D^%,>D4O)%0
M!("3D=$&+T<Y98_:*=_G-=@YOCPFC.E;A#'-#NEK=/]W95LO+\ 9^HSUWK .
MPTYT(3I?*G##8!GI*CD@!V.^D&WW2<D<"V3,:Z(-'H[HC?\S4#='<(I$$>!<
M#P X^,QKU">/T-QP4RY]P#B!LTYZ= WIU.UP*JDM,>;>P3RDB7%=2%3.LP#3
M!M%88&>^@#FI" !G)?-%"*#A'GKN:[IES'\]ELP+,4\-&KY+G*, A+.E )Q<
M  Z-V9J1=9L@;4<"&<6O\X9YAW22"TGYF2\C..[#][D/"K<O+N_<J!E \T-5
M 6DNO0# Z5\U>GP,<S6UPX^D<_^<C*(K)/*&YDA[021NO\N C&X^2//%GP%L
MT<]G<%2/;OX$D1HB6L.<P9MSAGDVW].P_B@C8)[21"0KYNXE$DP)_E\;8(S0
M&H5[ '2J-L;NQG9/_D<_@*P8>]ALD1PNGZT"6JT),.J,[GV-OG<_P"@1F6).
MHFL<B&NA7R"(",*XEK9<*Z]+NO6W**)7D&IDH*T0-4MVZ3?SZ@K^FV&]P* )
M7\/>5G+?%'V4".#\@P$N6M?I6:;&XF2/@2_(L(^*Q>WCZ&]3H@ES;T3?RKFZ
M2 #'#^-.*MB?G*\4.5]_ER!()3J/05( &.D^Y! 7(AV.E_D*'#?4CX]26UQ&
M/Y_B>N$4-Y7>+=G2L5V3%VX)\ 8I/\K5+><1]IMQ1;C^ 8C(:0Z'3&T-]62J
M8T?'3^]+?8#TJE;JHYMHW#U+/W_8A]+\5KI^]@'2O9E3Z%TQMRA=Z.:#C-*:
M^-A1T5I['UX<BQ61S_V43#%9D7OWPYS'QASOHM B189YP?<D8TBC!6P P \X
M?"#74P!.MP X"&D'< ,>%.$8V?N2@;I[V87:J,:P&P'8(7JLF-VR@@$<&'Z(
M-(G;=])]+X##E>_S,E]'W-R+'*Y]V #5[2.TN'F*QEP YDUB-XW!H7R-^(7"
M$;);8'CRKF%W''"6R6E"F\MQ\Q#=_[]:\1%%JX@M.0[LYR)&XSFL2\.M;:H*
M2)'I*0!'.(3VO7(7^.C<^D#&?=S<&TX(QBWF/G"0:>#WP/PI0+U"G./78,CS
M^!W1N'TA<V 1 ,X2..)RIQ\[X5.Z9<QW2L(:#V<<'!R%[I2OPP!.%0.A-);
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M.2UA7=(+?^YZV8<D4?A*&655B0#.4C%'9&\'@38BP4"(KOB7%("C !P%X"@
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M[R!GE8S\DH6=7NM5^OD-:1BOZ.T #O>Q8;^+''4R=I\!7P<9JO\HAY##<!O
MBL@(^T<HS<DI%14-X#CK(<P;?"4HL4I&YQ6R9/2GDN-FK02_TK&_G9[CQ%AB
M[.@N'QQU=>NSPPMGS; !3/Q=AO9_M7;>&NLKU@/#/@[A[%PYA'>/6_OC#-X"
MX:S:]V(,Y5F5!4[MK%BM-1X16.7D6NHY (<<VJ%U$3@<7')7-R^1?!$?Y#4/
MP)$Q,$[,8PJIV%4$@-,A2Y:_+SD]GB[7F,?[T[M=%S.LLZ,)Z]!2]5P!. K
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M>9,\(SR4(V\ WOC9=ZBO5[@B;:JR>:3\[,>.E[T'P-3DYN!'*&>O>EX!. K
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M^[*L-K52CI-*!SLS-.[_X_K9!Y)^YI>NG][3.2G49EP1K@\ 2VF! G 4@*,
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M=:'V_P   /__W/L09@  /^Y)1$%4[%T'>!S5M9:!8&T1F&*,3;%V9BW;,7$
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M:$YOM-/9ITG.WZ-_K]D(Y3;':Y>];_)/VNG<I:ET]DCGK+9O*ZE0 (X"<!2
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M2,^: .%Q%GA+WF.CKMJL@U=%E\\J,BRK8I-&"\X.ZP(:US>"RCR-^YL1W;B
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M\UB0%X<#>WHQL(HU\0^$W6U#?1FR:]V0GO+64@!.5W2-NB'R?+TFK%M/!\F
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MF:"XR=^-0]O<[ S;]<^D>;I<@C=OV%[^<RFG X5PNX7EU,T^DG(SYTQSLS]
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MQ\V_*\.B6L78Y&F,\EFJN0'.J;3^ZN4^)CF9-\W+'0^NH$-H?+$6%6FQ*@K
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M+9VC*S02B-TUY\9WKKA_L9V#U;TQ;C(N7*YRWZ-J,BLU;DY?)ONR@@$
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MGF-7SNC896/:#;>=G7>VV=CJ7F/]S[0+UYA&N"C-N(G?56;+][P\G+@]WP8
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MRGG_JJ73QH4=TFFD/:_-AS7&I\OD$3,^QA,<#QH?IDE.M$_&Y'-L*C0 =PP
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7F=\ 9^7_;0B#S5<     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 23, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 23,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Bicara Therapeutics Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-2903745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">116 Huntington Avenue,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 703<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boston<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">468-4219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BCAX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0002023658<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bcax-20260723.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bicara.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="bcax-20260723.htm">bcax-20260723.htm</File>
    <File>bcax-20260723.xsd</File>
    <File>bcax-20260723_lab.xml</File>
    <File>bcax-20260723_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "bcax-20260723.htm": {
   "nsprefix": "bcax",
   "nsuri": "http://www.bicara.com/20260723",
   "dts": {
    "inline": {
     "local": [
      "bcax-20260723.htm"
     ]
    },
    "schema": {
     "local": [
      "bcax-20260723.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "bcax-20260723_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bcax-20260723_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://www.bicara.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bcax-20260723.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bcax-20260723.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.bicara.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001628280-26-049937-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-26-049937-xbrl.zip
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M- 1D%NRB53%@PB5KVD^FBW%7>&I$:%F:Z6AFV.7MUXUI%XVB;5AVTLE8\F5
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ML"FC ?0W.8T[#8-ATS9K,#K";%"/W_M-!Q:!B7B(I!<G\ +1_+&H_IWV $G
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M#1(Y%)-VX&95*+KI&,8(V5 $#]C/5'>60;\SCXZH8!L+OI>"5240%6;0P S
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MR%88B?HN^9L/ 6<NVY=X72HE#@&'FQ,S,N*Y8#1#OG:N5;5J\\3[=@L>^10
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M^:+21F,4Q=V9B]+FD.AY2^Z=DZ^_,L$&$_)>[0_ER4W?O##U\O<%F&<3\@4
M8.*@,; 91U<3CHZ&,=\ IZHM'#>3^K85&^1GJ)5JS()8..%OER,6L_&8>& )
MY\8O@M=&VABV)5= V5J 8-M^X+EQ+C-!R]6;)<N4CZCO1V#>@E.L)@U@2 P"
MX<N@7]#5 [CK2.&ZCSYXB;K0@0 >I&$_'[-?>M8.9AX\4"^O$'#" 9HL-6P
MQW<#I#$#",QD0T"4B%"A23I#_S"S+ELOP#(2<I9WL*I#(@1-%.0Q$EP&,F>@
MG.RP3T,]*"H&8<;$H+"*8C%&IDK7=-D0'Z;YEG'2)_"TVK[S /M9QR6AUB5A
M#Q-4"?H&?FQE)?)1LEGHY2SM<M\!XU:J24.K*.P' IC,)<AJ696A9+0/ "IY
MROQTH>6B+E";.W-(V]+@.219<H[JR#>8/L;%9B%?O;PC[GDH:ABBQ4E,0X[E
MHF8RL7VX *4.:X@C_ 5\H,L:* X E:46$L\T*RNC5,\W*D4B^U0LJ*N4G1P=
M$=8]X*0<*ON9&2@7&E[E(N%@;)5:"LCBP+$X3^4\"U<)OWEUFPX(;G, ':AB
M@DQW!K9BJ,IV7@-4EPG>$B.)M&<G<X.Z> )"!Z8P5-G&>NM@5K/KO&:)I-?#
MTYOI7#J7;25_?,+&?=[E8:+MYR?Y[T@5B  6CXN_X$%03*"VBL:_$X20OW0K
M H.I32$V!'>G"S=*Q<2P>;EDO)I6@9R4P87^'%I%@$/$NHJ]T*PP29=$2;E1
M$(&$%UCW4B!?2,<+)'J$6IHI9[%<+,?AE%MV'WEZT3O&1ZUF,)S)X@G GUFG
M2>A>E.S#& H([7#$0/*L <1W=<JZBI*"P2?GLS)2VIJ0$8XLDP 41DD3OE:2
M%"/TFE]7C]>GP-QZZ\O7F]Y J8%F:Y<-_.E9SS5F*W"/Q$VRV6<8K4&4K>QF
MD5_0:AYB^$OG^R.?**@N8\:PBF9Y%7<D1T?TVB#K:D,QYI&.817.\6K*$-JL
M*A^V5-_21M;"<.HR_3;$BDWRH$%<"]#E!GIYM2D[0_:IX:=LO8$F@:1#4&7A
M)H[F7,.I*RG8T*,."MPV%8$W\<GU?6PZY[4=.L?B.+/K^Z6SDD^TYZ=S6/!<
MU?N_TJ^@;?A HD"(IQ:;R1E4Y>?G^A''_(4^<$^)NYDISTW89R-D6^ WP/\G
M&OG T[<,-Q_QQ.,&^%W]SA352L#@#-,9454\B:?+N;J7O)9TJ2'/T=#&2DR*
MPF3D@ \M,02"TCP5JS!$:M;DIT:\?G]#,SY]2\GU$0>+=L;>[DZF"'G)^OEN
M+?:5?(^I8S4WIY8,Z+QA()D^*8M['=J-0 ZXYXY:EC0@ M;G?<2UE0<$"C#0
M>Y9$"K)FV#+_8JD%R@1NOL2%6Y*!)VI<3\,H4AACQJ N;MW,QH%P@)C$%.>D
MTY^.H+6GFX1V#EL?/;K\&NZ^VK'-^I,SPA@=91E',I3AI>TE7/FI0^FHI:=*
MY$Y-^T3D?+NSF1AOCU61S"OA'+L&L])JMG'J4+_<U3M'%30-5B*@&CY<2ND(
MWD6^[8+NT0IW3OBG2R2S\AU%J>)[/'NYY+CE<5OMZ=MJN\Z1;E3-LEW?^LAI
MQ;0:U6?):Z[89K6XYSIVCV4L[8F!UZ4XSMFMWU(7IKH46'V+JSA@T["V.G/>
MAIZZ@J_*+[ V$EY*_F)6RLKDAN^(^6P6K&U62@A_QP$T0L<@)$.PN<E)&XW4
M1^M[[A;YCV/@Q>&_;%H51,%G#NJ+>>0F&#'/BUV>(_9WA/UENTC;(7^E2-VJ
M-,.+D,^9:/+47U+NB'6*<<78$CLL\GVMDGNIY#C*[QU+$+US&PPQ#OX^& %V
M\N3S483O;@$R<;_O*+N_ZSG<%Z@-MHK['KEAG^;D42GL6BG,;Z\<,;]3=;PR
MK>YHRFOAO7K[X[ H];7:[MG-RJ-X?FE>_Q'YAR^AUYP_W4M*F#;)U*$R[D<Z
M^RO-46C/I@;H'?;]'UQY_(!2S2Q:YFR^V8<+<I%FI[WD)($TK[V>Y+5G-NBQ
MZI-+*":"22S&XF%V+U$?E7;34RE+#J&<^WX0J8\ISV04R(63 DN."""Y+!Z#
M,>,M77*>9JF%F(">G1?<Z$7"Y[*?355K-$Q+IZI!BW8D!.8BS.5MUHV/+WB[
M&#?[N9]^4!T8+L0-_+ _FSF)5#R;+3R+GOQ\N=\NF\4E+)/L4\]3:9U=3)=A
M@RD%J-S 9(4P;R#.%E$+GIZ"K2\[ IM//T"DTG!DU/TSSL[ EAZG7>[I; #U
M,@T!-$>G4?KPIIX4GYW3]),_.I<G_>:VRC_V)TFUXI4U176F06DVTT#-<G'J
M;.RPH?J '!LK2L2ZR"GF8>SXNW).=A(R IM4SV*C\_&6O8_:9(ID&D RQ" ?
MTM//:3*G3K.)2>C14'C\7=\]?/;/?:M.54RK3<>)W3JMK,OPELYMQ<QA3!'Z
MIQ6A;IA5:[M"9ZL3!6J/?-=NTSG5JZ;]2&7L;5,+B/YEFW-?\_F6#S#LNA+*
M.E\WD>;7@;EU1+>("(J1O04N:^77BLP+E6.ECLNL+C0UGRRE67XI!E?6+MEP
M!7;W_GXR=A8+=*ZFAEYOU]1P1I-I8/4@ QKB&=]FK$E.]SDWTA=8MN-/L.'1
M?.^BY1SI<P9#\9\>]\U^"+R')MY9@6Z_U[.M9#B2PTL@AQOE-MUJMRE/7&4K
M*_IX\:#%WNSK ";Y:OOK@&7J3[X.B!*'X75 8Z[0#SO_%/62LJ7URCY\1ZM8
M/CQ]N?]2YLN1U<9T"')#[QFYPK.K5!_CNJ AU5_(/<$3"BY&EY!GN*[X<*5<
M7O+'^]M/Q V<"",+V]<K/YY6>)8B8'LK]WWU\_7YW6^WEYN$6#.3W/TFP7+B
MOYDY$;YPD"J.>FYQL$D'X6^SE0U=-&P<&NGJ&ARCWBJ K6.U<26IP"<8VNJR
M/O5ZR4E&?>Q=-T"=%>&9<M7=M$+'$V/?3R_<]UQOSFU**AFX\\A;HV8VK.K6
M7RMHF.5:[7GB96;5?IY#/56S6'Z>3]*5+;-<J3Q'#&]#I;JT6?7QB.!AAK#F
M=[Z7?Q-\506XC:-6UKJPU7,LP+<WVTM(:O=%KO&\=3.[&WO@YJ>UQ/BL[<54
M?S]9]N6/+7<&#E,.;$8\!5G FFE8-B<I-O%T7^YY^?C5$1O6E-^<W&+C0VWD
M A[ P^ NP?F=ODI"G"/"I6EG1UI\-EI4'_#XA\N^=I^S'CA5X&"IF$-<$_E5
MAA$*W<"=P)]^./!:_P502P,$%     @ :63\7+WX(55? @  \P8  !$   !B
M8V%X+3(P,C8P-S(S+GAS9,U4R6[;,!"]^RM8G4NMCAT9L0,T08 "[@(W07,K
M*&ID$Y%(E:1BY^]+TB(<)7$*]U2=J)GW9N,;7ESNFAH]@E1,\'F0A'& @%-1
M,KZ>!W>W-_@\N%R,1A<?,+[_M%JB:T&[!KA&5Q*(AA)MF=X@O0'T4\@']DC0
M]YKH2L@&XX6C78GV2;+U1J,T3B<>YKUR%B=Y1<[B$E=9,<'3Z3C!Q3DI\-DD
M3:KD;%I,)OG']8Q.(*5Y?([3C*1XG%: 24[&>$(S2O-B2HM\ZH+NU$S1#30$
MF=:XFNW4/-AHW<ZB:+O=AMLL%'(=I7&<1/=?EC\<-.BQ->,/ _2ND+7'9Y%U
M%T2!AQ>4[ ;P@E$B24A%$]EFXVF:!8AH+5G1:;@Q4[F&BG2UG@<=_]V1FE4,
M2C/R&NQ0!X!G;DWD&O17TH!J"86_IER,$+)S8$TKI$;\3>*P-<:5)IR:UO;#
M6PI*M-/$48K]PYZ'K0DG*<Z2<*?*(/J'&@[C/:T&SSN]!A=, 0W7XC$J@=D1
MCM].KX[![0';PS GX5QHQ[>6WM:VC%=B;S F6_C,5[^"RBOVE0Q[T29YGD?.
M:Q3HR$12*6IX'QRU4K0@-0/U7,(NP$9"-0^LD+&7SZ]60F@J\9!7"8978-TF
M R@C8-?O\M"0#Z&?6A-"F7NH83^B_[G_FA2G]F\H4)_8N"7>&C]BY3RX$N81
M#I"UW:T^']MPEVL/];%\M!(JQIG36^R^!.'#:XV18UU$+[$OHG0*RF]\X<XO
M[[0G]Y!WB)34M*M/YQW*.DKKC7YT_6I%P]W:_S_;/V?8+_5B] =02P,$%
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M#6>01<4*CH([M?)-IPF]XDT[W'BEFTXKC<)-=ZN!8]AMOBQP^I_D47@G36!
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M0_;5"N..O;6VSYQ@=VUO\RY$Z^_&#3^Z.-D^DJR_N_GBY']02P,$%     @
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M;</QYW?G5W*FYQRD>5GQ7-8&RO2H; Z>%Y)7C>H_[%?P9(OZ&U@W _4A$"*
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MP4 MNC4!0LD(X$10HA(C(XG_%S!0)S#HKP?&SVGJ$Q@3]_&#O2[N\FT7"$:
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MS3_WNM+V""V^QATIF5)J0YTVG;)-6Y+P_T<%WMM$L[N'D+_T)8K*9 NV^<9
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M,#(V,#<R,RYH=&U02P$"% ,4    " !I9/Q<O?@A55\"  #S!@  $0
M        @ %A%@  8F-A>"TR,#(V,#<R,RYX<V102P$"% ,4    " !I9/Q<
M'D:W.<\)  "+6P  %0              @ 'O&   8F-A>"TR,#(V,#<R,U]L
M86(N>&UL4$L! A0#%     @ :63\7$MO#98N!@  "S4  !4
M ( !\2(  &)C87@M,C R-C W,C-?<')E+GAM;%!+ 0(4 Q0    ( &ED_%SI
ME.O5EQ,  "Q$   >              "  5(I  !J=6QY,C R-F)O87)D=7!D
D871E<W!R7V9I;BYH=&U02P4&      4 !0!0 0  )3T

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>bcax-20260723_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bcax-20260723.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002023658</identifier>
        </entity>
        <period>
            <startDate>2026-07-23</startDate>
            <endDate>2026-07-23</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-24">0002023658</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2026-07-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Bicara Therapeutics Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-42271</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">83-2903745</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">116 Huntington Avenue,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">Suite 703</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Boston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">02116</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">468-4219</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Common Stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">BCAX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-22">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
